CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report

Neurol Sci. 2014 Jul;35(7):1151-2. doi: 10.1007/s10072-014-1709-5. Epub 2014 Mar 14.

Authors

Tommaso Schirinzi¹, Giulia Sancesario, Lucia Anemona, Antonio Pisani, Giuseppe Sancesario

Affiliation

¹ Neurology, Department of Systems Medicine, University of Roma Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy, [email protected].

PMID: 24627229
DOI: 10.1007/s10072-014-1709-5

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Deferiprone
Humans
Iron Chelating Agents / therapeutic use*
Male
Pyridones / therapeutic use*
Siderosis* / cerebrospinal fluid
Siderosis* / diagnosis
Siderosis* / drug therapy

Substances

Iron Chelating Agents
Pyridones
Deferiprone